Eisai and Biogen said their experimental drug on Alzheimer’s significantly slowed progress of the disease by 27% compared to a placebo, offering the promise of an effective treatment to desperate patients and their families https://t.co/cLTnYmxc3j pic.twitter.com/CIJydN1G0X— Reuters (@Reuters) September 29, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


